
Yüksel Ürün
@dryukselurun
Medical Oncologist, Prof.Dr. @AnkaraUni - Genitourinary Cancers Expert - Believer in Science - #Diversity #Equity Advocate
ID: 2798480350
https://yukselurun.com/ 01-10-2014 17:42:21
13,13K Tweet
8,8K Followers
585 Following

Final MAGNITUDE 📢 In mCRPC with BRCA mutations: Niraparib to Abiraterone = ⬇️ progression risk by 47% ⏳ rPFS: 19.5 vs 10.9 months 🧬 No benefit in non-HRR pts ✅ Confirmed the biomarker-driven benefit! European Urology Oncology OncoAlert Advanced Prostate Cancer Consensus Conference Elena Castro AttardLab
